USFDA approves use of Promacta for use in children aged 1 and older Meghna A Singhania25 Aug 2015 5:07 PM ISTFDA expands use of Novartis drug Promacta ® to include treatment of children ages 1 and older with chronic immune thrombocytopenia- New oral...
USFDA approves Novartis' heart failure drug Meghna A Singhania8 July 2015 1:21 PM ISTUSFDA has given its nod to the combination drug, Entresto made by Novartis to treat heart failure. This approval comes being based on studies having...
US points corruption allegations at Novartis Meghna A Singhania4 July 2015 1:02 PM ISTSeeks $3.3 billion as fine from the drug manufacturer.Swiss Drug Maker, Novartis has seemed to rub the US authorities on the wrong side of the duty,...
Novartis steps up its pain management drug portfolio Meghna A Singhania30 Jun 2015 11:18 AM ISTTo buy U.S. Australian biotech firm Spinifex PharmaceuticalsSwiss Drugmaker Novartis has decided to invest in the potential of new medicines,...
